Artificial Intelligence-Assisted Design of Nanomedicines for Breast Cancer Diagnosis and Therapy: Advances, Challenges, and Future Directions

Проектирование нанопрепаратов с использованием искусственного интеллекта для диагностики и терапии рака молочной железы: достижения, проблемы и перспективные направления
Mina Shaban, Sonia Fathi‐karkan, Abbas Rahdar, M. Ali Aboudzadeh, Zelal Jaber Kharaba, Vahideh Mohammadzadeh, Moein Shirzad, Zakieh Sadat Hoseini, Mehrdad Najafi, Maryam Shirzad, Mehrdad Najafi
2025-05-21

AI-assisted nanomedicinebreast cancer diagnosisdeep learning modelstargeted drug deliverytheranostic nanoparticles
This paper explores the revolutionary collaboration between artificial intelligence (AI) and nanotechnology in detecting and treating breast cancer. It highlights the synergistic potential of both fields to overcome significant limitations of modern approaches. Clinical applications and research demonstrate the diversity and depth of AI-based deep learning models in diagnostics, improving diagnostic accuracy and enabling precise, individualized therapy through advanced imaging and biomarker discovery. Through intelligent nanocarriers, nanotechnology contributes to these advancements by enabling targeted drug delivery, minimizing systemic toxicity, and providing theranostic capabilities for real-time monitoring. However, challenges remain, including data accessibility, model interpretability, scalability in nanocarrier manufacturing, and tumor diversity. Future improvements should focus on developing multifunctional nanoparticles, flexible AI algorithms, and scalable, cost-effective solutions to enhance accessibility and clinical integration. Hence, the study emphasizes the need for multidisciplinary collaboration to eliminate existing barriers and generate advancements to transform breast cancer therapies into more effective, safer, and individualized methods. Graphical Abstract
1
AI enables more precise and individualized breast cancer therapy by supporting patient-specific diagnostic and treatment decisions.
2
AI-based deep learning improves breast cancer diagnostic accuracy through advanced imaging analysis and biomarker discovery.
3
Future progress requires multifunctional nanoparticles, adaptable AI algorithms, scalable cost-effective solutions, and multidisciplinary collaboration for clinical integration.
4
Intelligent nanocarriers facilitate targeted drug delivery, reduce systemic toxicity, and provide theranostic capabilities for real-time monitoring.
5
Major barriers include limited data accessibility, poor model interpretability, difficulties scaling nanocarrier manufacturing, and tumor heterogeneity.

AI-assisted nanomedicines for breast cancer diagnosis and therapy

Integration of AI-based diagnostic and therapeutic capabilities with intelligent nanocarriers to improve diagnostic accuracy, enable individualized targeted treatment and real-time theranostic monitoring while reducing systemic toxicity

Publication Details
Publication Date
2025-05-21
Journal
Publisher
ISSN
Cited by
118
Access Type
Author Information
Authors
Mina Shaban
Sonia Fathi‐karkan
Abbas Rahdar
M. Ali Aboudzadeh
Zelal Jaber Kharaba
Vahideh Mohammadzadeh
Moein Shirzad
Zakieh Sadat Hoseini
Mehrdad Najafi
Maryam Shirzad
Mehrdad Najafi
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%